Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $112.56M.
ENTERPRISE VALUE (EV)
$112.56M
Pyxis Oncology, Inc.
Market Cap
$127.98M
Enterprise Value (EV)
$112.56M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | $127.98M | $112.56M |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | $101.85M |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | $240.18M |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | $182.86M |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | $113.82M |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | $123.59M |
| LifeMD, Inc. (LFMD)vs › | $132.03M | $112.91M |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | N/A |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A |
| BGM Group Ltd. (BGM)vs › | $122.43M | $112.09M |
Market Cap
$127.98M
Total Debt
$0.00
Cash
$15.42M
Enterprise Value
$112.56M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
